Yoon Sim Yap

11.1k total citations
125 papers, 3.0k citations indexed

About

Yoon Sim Yap is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yoon Sim Yap has authored 125 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 49 papers in Cancer Research. Recurrent topics in Yoon Sim Yap's work include Advanced Breast Cancer Therapies (35 papers), Breast Cancer Treatment Studies (30 papers) and HER2/EGFR in Cancer Research (26 papers). Yoon Sim Yap is often cited by papers focused on Advanced Breast Cancer Therapies (35 papers), Breast Cancer Treatment Studies (30 papers) and HER2/EGFR in Cancer Research (26 papers). Yoon Sim Yap collaborates with scholars based in Singapore, United States and South Korea. Yoon Sim Yap's co-authors include Raymond Ng, Kiley Wei-Jen Loh, Joycelyn Jie Xin Lee, Soo Chin Lee, Ann S. G. Lee, Nan Soon Wong, Rebecca Dent, Jongyoon Han, Bee Luan Khoo and Chwee Teck Lim and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yoon Sim Yap

118 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoon Sim Yap Singapore 30 1.4k 1.1k 727 640 491 125 3.0k
Jungnam Joo South Korea 35 1.2k 0.8× 1.2k 1.2× 539 0.7× 698 1.1× 349 0.7× 188 4.0k
Philip J. Stella United States 39 3.3k 2.4× 2.1k 2.0× 780 1.1× 1.0k 1.6× 329 0.7× 126 5.6k
Monica Fornier United States 34 2.5k 1.8× 916 0.9× 722 1.0× 889 1.4× 190 0.4× 110 3.9k
Mark Clemons Canada 37 3.3k 2.3× 1.3k 1.2× 1.0k 1.4× 894 1.4× 321 0.7× 218 5.3k
Sun‐Young Kong South Korea 32 1.3k 1.0× 498 0.5× 683 0.9× 1.4k 2.2× 310 0.6× 204 3.7k
Gary N. Schwartz United States 29 1.3k 0.9× 1.0k 0.9× 1.2k 1.6× 944 1.5× 187 0.4× 89 3.7k
Marek Z. Wojtukiewicz Poland 34 2.2k 1.6× 809 0.8× 939 1.3× 1.0k 1.6× 301 0.6× 190 4.5k
Stefania Gori Italy 30 2.0k 1.5× 897 0.8× 694 1.0× 680 1.1× 224 0.5× 180 3.5k
Tom Boterberg Belgium 36 1.2k 0.9× 1.3k 1.2× 422 0.6× 762 1.2× 68 0.1× 167 4.2k
Matteo Puntoni Italy 33 1.8k 1.3× 658 0.6× 1.2k 1.7× 1.7k 2.6× 668 1.4× 139 4.8k

Countries citing papers authored by Yoon Sim Yap

Since Specialization
Citations

This map shows the geographic impact of Yoon Sim Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon Sim Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon Sim Yap more than expected).

Fields of papers citing papers by Yoon Sim Yap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon Sim Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon Sim Yap. The network helps show where Yoon Sim Yap may publish in the future.

Co-authorship network of co-authors of Yoon Sim Yap

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon Sim Yap. A scholar is included among the top collaborators of Yoon Sim Yap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon Sim Yap. Yoon Sim Yap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Siqin, et al.. (2024). Can metastatic breast cancer be cured? Long-term follow up of patients diagnosed from 2001–2012. European Journal of Cancer. 200. 113713–113713.
2.
Kim, Jae Hyeon, Kyung-Hun Lee, Y.H. Park, et al.. (2024). Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study. ESMO Open. 9(11). 103732–103732. 3 indexed citations
3.
4.
Yap, Yoon Sim. (2023). Outcomes in breast cancer—does ethnicity matter?. ESMO Open. 8(3). 101564–101564. 12 indexed citations
5.
6.
7.
8.
Chiu, Joanne, Fei Su, Norikazu Masuda, et al.. (2023). Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial. BMC Medicine. 21(1). 306–306. 13 indexed citations
9.
Prat, Aleix, Nadia Solovieff, Fabrice André, et al.. (2023). Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7. Clinical Cancer Research. 30(4). 793–802. 8 indexed citations
10.
Ithimakin, Suthinee, Napa Parinyanitikul, Sung‐Bae Kim, et al.. (2022). Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories. Journal of Breast Cancer. 25(3). 207–207. 5 indexed citations
11.
Iyer, Arvind, Shreya Sharma, Kishore Hari, et al.. (2020). Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells. Journal of Clinical Medicine. 9(4). 1206–1206. 28 indexed citations
12.
Dawood, Shaheenah, Chiun‐Sheng Huang, Shona Nag, et al.. (2020). Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors. Current Medical Research and Opinion. 36(8). 1363–1373. 5 indexed citations
13.
Yap, Yoon Sim, et al.. (2019). Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer. Journal of Breast Cancer. 22(2). 260–260. 2 indexed citations
14.
Iwata, Hiroji, Norikazu Masuda, Sung‐Bae Kim, et al.. (2019). Neratinib After Trastuzumab-Based Adjuvant Therapy in Patients from Asia with Early Stage HER2-Positive Breast Cancer. Future Oncology. 15(21). 2489–2501. 7 indexed citations
15.
Yeo, Winnie, Takayuki Ueno, Ching‐Hung Lin, et al.. (2019). Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression. Breast Cancer Research and Treatment. 177(3). 549–559. 26 indexed citations
16.
Ng, Terence, Yin Ting Cheung, Hui Ling Yeo, et al.. (2018). Distinct and heterogeneous trajectories of self‐perceived cognitive impairment among Asian breast cancer survivors. Psycho-Oncology. 27(4). 1185–1192. 46 indexed citations
17.
Munusamy, Prabhakaran, Hai Yang Law, Seung-Chul Yoon, et al.. (2017). Identification of Novel Breast Cancer Risk Loci. Cancer Research. 77(19). 5428–5437. 11 indexed citations
18.
19.
Teo, Yi Ling, et al.. (2012). Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence. Breast Cancer Research and Treatment. 133(2). 703–711. 54 indexed citations
20.
Hughes, Sarah, Yolanda Barbáchano, S. Ashley, et al.. (2008). Time Trends in the Outcome of Elderly Patients with Breast Cancer. The Breast Journal. 14(2). 158–163. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jungnam Joo Breakdown of academic impact, for papers by Philip J. Stella Breakdown of academic impact, for papers by Monica Fornier Breakdown of academic impact, for papers by Mark Clemons Breakdown of academic impact, for papers by Sun‐Young Kong Breakdown of academic impact, for papers by Gary N. Schwartz Breakdown of academic impact, for papers by Marek Z. Wojtukiewicz Breakdown of academic impact, for papers by Stefania Gori Breakdown of academic impact, for papers by Tom Boterberg Breakdown of academic impact, for papers by Matteo Puntoni
Rankless by CCL
2026